Study to Assess the Efficacy, Safety, and Tolerability of ADL5747 in Participants With Postherpetic Neuralgia
Status:
Terminated
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the analgesic efficacy of ADL5747 in
participants with postherpetic neuralgia (PHN). The secondary objective of this study is to
evaluate the safety, tolerability, and pharmacokinetics of ADL5747.